IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 94

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Review On Drug Discovery And Development
Authors Name: Tanuja Bhausaheb Kolhe , Gajanan Keshav Gajmal , Ayaz Ahmad Aadam Shah , Dhananjay Machindra Patil , Deepak Devidas Sonawane
Download E-Certificate: Download
Author Reg. ID:
IJNRD_182893
Published Paper Id: IJNRD2209060
Published In: Volume 7 Issue 9, September-2022
DOI:
Abstract: Finding a therapeutically effective molecule for the treatment and cure of disease is the goal of drug discovery. The selection of candidates, synthesis, characterisation, validation, optimization, screening, and tests for therapeutic efficacy are all parts of this process. A molecule will start the medication development process prior to clinical trials once it has demonstrated its importance in these studies. A new drug must go through a number of stages of development in order to be produced that is both safe and efficient and meets all regulatory standards. One overarching theme of our article is that because the process is so drawn out, expensive, and complex, numerous biological targets must be taken into account before any new medication is finally approved for clinical use. Additionally, new research tools may be required to examine each new target. It takes time and effort to develop a drug that can be sold. From the time of discovery until the treatment is licenced, it takes roughly 12 to 15 years and costs about US $1 billion. A million molecules are typically tested, but only one is examined in advanced clinical trials and ultimately made available to patients. An overview of the procedures for discovering and developing novel drugs is given in this article.
Keywords: Lead optimization, clinical trials, target validation, identification, Clinical Phases, Clinical Phase Trials, Preclinical Trials, Federal Drug Administration.
Cite Article: "Review On Drug Discovery And Development", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 9, page no.508-519, September-2022, Available :http://www.ijnrd.org/papers/IJNRD2209060.pdf
Downloads: 000118746
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2209060
Registration ID: 182893
Published In: Volume 7 Issue 9, September-2022
DOI (Digital Object Identifier):
Page No: 508-519
Country: Nashik, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2209060
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2209060
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD